Graham P. Allaway
No más puestos en curso
Perfil
Graham P.
Allaway was Chief Operating Officer of Panacos Pharmaceuticals, Inc. from May 3, 2005 to February 27, 2009.
Dr. Allaway was Senior Vice President for Drug Discovery at Boston Biomedica Inc., which he joined in 1998.
Prior to this, he was Chief Executive Officer of Manchester Biotech from 1997 to 1998.
Dr. Allaway received his MA in Zoology from the University of Oxford and his PhD in Virology from the University of London.
Antiguos cargos conocidos de Graham P. Allaway.
| Empresas | Cargo | Fin |
|---|---|---|
| PANACOS PHARMACEUTICALS, INC. | Fundador | 27/02/2009 |
Panacos Pharmaceuticals, Inc. /Old/
 Panacos Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Panacos Pharmaceuticals is engaged in the discovery and development of small molecule oral drugs for the treatment of HIV and other major human viral diseases. Panacos’ proprietary discovery technologies focus on novel targets in the virus life cycle, including virus fusion and virus maturation, the first and last steps of viral infection | Presidente | 03/03/2005 |
Manchester Biotech
 Manchester Biotech BiotechnologyHealth Technology Manchester Biotech is an American biotechnology company. | Presidente | 01/01/1998 |
| PRESSURE BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Formación de Graham P. Allaway.
| University of Oxford | Graduate Degree |
| University of London | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| PRESSURE BIOSCIENCES, INC. | Health Technology |
| PANACOS PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Panacos Pharmaceuticals, Inc. /Old/
Panacos Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Panacos Pharmaceuticals is engaged in the discovery and development of small molecule oral drugs for the treatment of HIV and other major human viral diseases. Panacos’ proprietary discovery technologies focus on novel targets in the virus life cycle, including virus fusion and virus maturation, the first and last steps of viral infection | Commercial Services |
Manchester Biotech
Manchester Biotech BiotechnologyHealth Technology Manchester Biotech is an American biotechnology company. | Health Technology |
- Bolsa de valores
- Insiders
- Graham P. Allaway
